PP-046 A stability indicating hplc-uv method for quantification of simvastatin and detection of its impurities in oral capsules

PP-046 A stability indicating hplc-uv method for quantification of simvastatin and detection of its impurities in oral capsules

BackgroundA clinical trial sponsored by our hospital wished to compare HMG-CoA reductase inhibitors versus placebo for children with genetic diseases. For this purpose, and because the dosage in unavailable, our laboratory is in charge of the galenic development of simvastatin capsules and its place...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of hospital pharmacy. Science and practice 2017-03, Vol.24 (Suppl 1), p.A221-A222
Hauptverfasser: Merienne, C, Semely, D, Wolff, E, Roussiere, A, Tafani, M, Ramjaun, Z, Caturla, L
Format: Artikel
Sprache:eng
Schlagworte:
Statins
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A222
container_issue Suppl 1
container_start_page A221
container_title European journal of hospital pharmacy. Science and practice
container_volume 24
creator Merienne, C
Semely, D
Wolff, E
Roussiere, A
Tafani, M
Ramjaun, Z
Caturla, L
description BackgroundA clinical trial sponsored by our hospital wished to compare HMG-CoA reductase inhibitors versus placebo for children with genetic diseases. For this purpose, and because the dosage in unavailable, our laboratory is in charge of the galenic development of simvastatin capsules and its placebo. According to GMP, the stability of the simvastatin capsule is evaluated.PurposeDevelopment and validation of a stability indicating HPLC-UV method for simvastatin capsules.Material and methodsThe HPLC system is a Thermofisher P4000. The column is an inertsil-CN, 250×4.6 mm with 5 µm particle. The mobile phase is an isocratic elution made up of 0.1% acetic acid buffer/methanol (50:50 v/v) at 1 mL/min flow rate. λ is included between 200 and 400 nm. Maximal absorbance of simvastatin is 237 nm. Calibration standard curve is between 30 and 70 µg/mL. Niacin is used as the internal standard. Linearity, trueness, accuracy and limits of quantification were evaluated according to SFSTP recommendations. Impurities were searched from SCR impurities of simvastatin dust according to pharmacopoeia 8.0. The matrix effect was evaluated.ResultsLinearity for simvastatin was validated with r² >0.99 and SD 1.5.ConclusionA simple and rapid stability indicating HPLC-UV method was developed and validated according to ICH and SFSTP international recommendations. It will be used to evaluate the stability of our simvastatin capsule. We already have 3 months of validated stability.No conflict of interest
doi_str_mv 10.1136/ejhpharm-2017-000640.493
format Article
fullrecord <record><control><sourceid>proquest_bmj_p</sourceid><recordid>TN_cdi_proquest_journals_2552763957</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4318073151</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1007-c933628318e53866666a59fa316c12078919540a3ac04f1dc6f8f77873294f8d3</originalsourceid><addsrcrecordid>eNp9kbtOAzEQRS0EEhHkHyxRO9hrrx9lFPGSIpECasu7axNH-8raGykdFPwoX4JDCCXTzGjm3jvFAQASPCOE8lu7WfdrMzQow0QgjDFneMYUPQOTDDOBlOLs_G_O-SWYhuALnFMqFaNqAj5WK4QZ_3r_nMMQTeFrH_fQt5UvTfTtG1z3dYnGHWxsXHcVdN0At6Npo3c_iq6FnYPBNzuT7MkBTVvBykZbno4-Buibfhx89DaNaTmYGpamD2NtwzW4cKYOdvrbr8Dr_d3L4hEtnx-eFvMlKgjGApWKUp5JSqTNqeSHMrlyhhJekgwLqYjKGTbUlJg5UpXcSSeEFDRTzMmKXoGbY24_dNvRhqg33Ti06aXO8jwTnKpc_KciKYtLKThPKnpUFc1G94NvzLDXBOsDFH2Cog9Q9BGKTlDoN8l3giw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1873688766</pqid></control><display><type>article</type><title>PP-046 A stability indicating hplc-uv method for quantification of simvastatin and detection of its impurities in oral capsules</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Merienne, C ; Semely, D ; Wolff, E ; Roussiere, A ; Tafani, M ; Ramjaun, Z ; Caturla, L</creator><creatorcontrib>Merienne, C ; Semely, D ; Wolff, E ; Roussiere, A ; Tafani, M ; Ramjaun, Z ; Caturla, L</creatorcontrib><description>BackgroundA clinical trial sponsored by our hospital wished to compare HMG-CoA reductase inhibitors versus placebo for children with genetic diseases. For this purpose, and because the dosage in unavailable, our laboratory is in charge of the galenic development of simvastatin capsules and its placebo. According to GMP, the stability of the simvastatin capsule is evaluated.PurposeDevelopment and validation of a stability indicating HPLC-UV method for simvastatin capsules.Material and methodsThe HPLC system is a Thermofisher P4000. The column is an inertsil-CN, 250×4.6 mm with 5 µm particle. The mobile phase is an isocratic elution made up of 0.1% acetic acid buffer/methanol (50:50 v/v) at 1 mL/min flow rate. λ is included between 200 and 400 nm. Maximal absorbance of simvastatin is 237 nm. Calibration standard curve is between 30 and 70 µg/mL. Niacin is used as the internal standard. Linearity, trueness, accuracy and limits of quantification were evaluated according to SFSTP recommendations. Impurities were searched from SCR impurities of simvastatin dust according to pharmacopoeia 8.0. The matrix effect was evaluated.ResultsLinearity for simvastatin was validated with r² &gt;0.99 and SD &lt;15%. Recoveries and bias were &lt; 15% for each validation standard. High and low limits of detections were far from the calibration standard curves. There was no matrix effect with the excipients. All impurities were detected and separated with a resolution &gt;1.5.ConclusionA simple and rapid stability indicating HPLC-UV method was developed and validated according to ICH and SFSTP international recommendations. It will be used to evaluate the stability of our simvastatin capsule. We already have 3 months of validated stability.No conflict of interest</description><identifier>ISSN: 2047-9956</identifier><identifier>EISSN: 2047-9964</identifier><identifier>DOI: 10.1136/ejhpharm-2017-000640.493</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Statins</subject><ispartof>European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A221-A222</ispartof><rights>2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2017 (c) 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>2017 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Merienne, C</creatorcontrib><creatorcontrib>Semely, D</creatorcontrib><creatorcontrib>Wolff, E</creatorcontrib><creatorcontrib>Roussiere, A</creatorcontrib><creatorcontrib>Tafani, M</creatorcontrib><creatorcontrib>Ramjaun, Z</creatorcontrib><creatorcontrib>Caturla, L</creatorcontrib><title>PP-046 A stability indicating hplc-uv method for quantification of simvastatin and detection of its impurities in oral capsules</title><title>European journal of hospital pharmacy. Science and practice</title><description>BackgroundA clinical trial sponsored by our hospital wished to compare HMG-CoA reductase inhibitors versus placebo for children with genetic diseases. For this purpose, and because the dosage in unavailable, our laboratory is in charge of the galenic development of simvastatin capsules and its placebo. According to GMP, the stability of the simvastatin capsule is evaluated.PurposeDevelopment and validation of a stability indicating HPLC-UV method for simvastatin capsules.Material and methodsThe HPLC system is a Thermofisher P4000. The column is an inertsil-CN, 250×4.6 mm with 5 µm particle. The mobile phase is an isocratic elution made up of 0.1% acetic acid buffer/methanol (50:50 v/v) at 1 mL/min flow rate. λ is included between 200 and 400 nm. Maximal absorbance of simvastatin is 237 nm. Calibration standard curve is between 30 and 70 µg/mL. Niacin is used as the internal standard. Linearity, trueness, accuracy and limits of quantification were evaluated according to SFSTP recommendations. Impurities were searched from SCR impurities of simvastatin dust according to pharmacopoeia 8.0. The matrix effect was evaluated.ResultsLinearity for simvastatin was validated with r² &gt;0.99 and SD &lt;15%. Recoveries and bias were &lt; 15% for each validation standard. High and low limits of detections were far from the calibration standard curves. There was no matrix effect with the excipients. All impurities were detected and separated with a resolution &gt;1.5.ConclusionA simple and rapid stability indicating HPLC-UV method was developed and validated according to ICH and SFSTP international recommendations. It will be used to evaluate the stability of our simvastatin capsule. We already have 3 months of validated stability.No conflict of interest</description><subject>Statins</subject><issn>2047-9956</issn><issn>2047-9964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kbtOAzEQRS0EEhHkHyxRO9hrrx9lFPGSIpECasu7axNH-8raGykdFPwoX4JDCCXTzGjm3jvFAQASPCOE8lu7WfdrMzQow0QgjDFneMYUPQOTDDOBlOLs_G_O-SWYhuALnFMqFaNqAj5WK4QZ_3r_nMMQTeFrH_fQt5UvTfTtG1z3dYnGHWxsXHcVdN0At6Npo3c_iq6FnYPBNzuT7MkBTVvBykZbno4-Buibfhx89DaNaTmYGpamD2NtwzW4cKYOdvrbr8Dr_d3L4hEtnx-eFvMlKgjGApWKUp5JSqTNqeSHMrlyhhJekgwLqYjKGTbUlJg5UpXcSSeEFDRTzMmKXoGbY24_dNvRhqg33Ti06aXO8jwTnKpc_KciKYtLKThPKnpUFc1G94NvzLDXBOsDFH2Cog9Q9BGKTlDoN8l3giw</recordid><startdate>201703</startdate><enddate>201703</enddate><creator>Merienne, C</creator><creator>Semely, D</creator><creator>Wolff, E</creator><creator>Roussiere, A</creator><creator>Tafani, M</creator><creator>Ramjaun, Z</creator><creator>Caturla, L</creator><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>201703</creationdate><title>PP-046 A stability indicating hplc-uv method for quantification of simvastatin and detection of its impurities in oral capsules</title><author>Merienne, C ; Semely, D ; Wolff, E ; Roussiere, A ; Tafani, M ; Ramjaun, Z ; Caturla, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1007-c933628318e53866666a59fa316c12078919540a3ac04f1dc6f8f77873294f8d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Statins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Merienne, C</creatorcontrib><creatorcontrib>Semely, D</creatorcontrib><creatorcontrib>Wolff, E</creatorcontrib><creatorcontrib>Roussiere, A</creatorcontrib><creatorcontrib>Tafani, M</creatorcontrib><creatorcontrib>Ramjaun, Z</creatorcontrib><creatorcontrib>Caturla, L</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>European journal of hospital pharmacy. Science and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Merienne, C</au><au>Semely, D</au><au>Wolff, E</au><au>Roussiere, A</au><au>Tafani, M</au><au>Ramjaun, Z</au><au>Caturla, L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PP-046 A stability indicating hplc-uv method for quantification of simvastatin and detection of its impurities in oral capsules</atitle><jtitle>European journal of hospital pharmacy. Science and practice</jtitle><date>2017-03</date><risdate>2017</risdate><volume>24</volume><issue>Suppl 1</issue><spage>A221</spage><epage>A222</epage><pages>A221-A222</pages><issn>2047-9956</issn><eissn>2047-9964</eissn><abstract>BackgroundA clinical trial sponsored by our hospital wished to compare HMG-CoA reductase inhibitors versus placebo for children with genetic diseases. For this purpose, and because the dosage in unavailable, our laboratory is in charge of the galenic development of simvastatin capsules and its placebo. According to GMP, the stability of the simvastatin capsule is evaluated.PurposeDevelopment and validation of a stability indicating HPLC-UV method for simvastatin capsules.Material and methodsThe HPLC system is a Thermofisher P4000. The column is an inertsil-CN, 250×4.6 mm with 5 µm particle. The mobile phase is an isocratic elution made up of 0.1% acetic acid buffer/methanol (50:50 v/v) at 1 mL/min flow rate. λ is included between 200 and 400 nm. Maximal absorbance of simvastatin is 237 nm. Calibration standard curve is between 30 and 70 µg/mL. Niacin is used as the internal standard. Linearity, trueness, accuracy and limits of quantification were evaluated according to SFSTP recommendations. Impurities were searched from SCR impurities of simvastatin dust according to pharmacopoeia 8.0. The matrix effect was evaluated.ResultsLinearity for simvastatin was validated with r² &gt;0.99 and SD &lt;15%. Recoveries and bias were &lt; 15% for each validation standard. High and low limits of detections were far from the calibration standard curves. There was no matrix effect with the excipients. All impurities were detected and separated with a resolution &gt;1.5.ConclusionA simple and rapid stability indicating HPLC-UV method was developed and validated according to ICH and SFSTP international recommendations. It will be used to evaluate the stability of our simvastatin capsule. We already have 3 months of validated stability.No conflict of interest</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/ejhpharm-2017-000640.493</doi></addata></record>
fulltext fulltext
identifier ISSN: 2047-9956
ispartof European journal of hospital pharmacy. Science and practice, 2017-03, Vol.24 (Suppl 1), p.A221-A222
issn 2047-9956
2047-9964
language eng
recordid cdi_proquest_journals_2552763957
source EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Statins
title PP-046 A stability indicating hplc-uv method for quantification of simvastatin and detection of its impurities in oral capsules
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T21%3A09%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_bmj_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PP-046%E2%80%85A%20stability%20indicating%20hplc-uv%20method%20for%20quantification%20of%20simvastatin%20and%20detection%20of%20its%20impurities%20in%20oral%20capsules&rft.jtitle=European%20journal%20of%20hospital%20pharmacy.%20Science%20and%20practice&rft.au=Merienne,%20C&rft.date=2017-03&rft.volume=24&rft.issue=Suppl%201&rft.spage=A221&rft.epage=A222&rft.pages=A221-A222&rft.issn=2047-9956&rft.eissn=2047-9964&rft_id=info:doi/10.1136/ejhpharm-2017-000640.493&rft_dat=%3Cproquest_bmj_p%3E4318073151%3C/proquest_bmj_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1873688766&rft_id=info:pmid/&rfr_iscdi=true